Elevance Health Inc (ELV · NYSE)

ELV · MARKET VIEW

Market view · as of Jun 22, 2026

Revenue (TTM)
$200.42B
+2.6% YoY
Gross margin
25.9%
EPS (latest q)
$12.58
vs $10.81 est · beat
52-wk position
77.8%
-8.1% vs 52w high · -1.5% 1mo

Price (last ~year)

Elevance Health reported $50.18 billion in revenue for the quarter ending March 31, 2026, bringing its trailing twelve-month revenue to $200.42 billion. Although the company achieved a 2.6% year-over-year revenue increase, earnings fell 16.8% over the same period, even as it outperformed analyst estimates in three of the last four quarters. The stock is currently priced at $388.50, reflecting a 34.4% gain over the past three months.

Valuation

Market cap
$84.37B
P/E
16.48
PEG
1.422
P/B
1.922
P/S
0.421
Beta
0.682
Analyst target
$415.81

Quality & returns

Gross margin
25.9%
Operating margin
5.3%
Profit margin
2.6%
ROE
12.1%
ROA
4.0%

Price movement

Last
$388.50
1-month
-1.5%
3-month
+34.4%
RSI (14)
49
vs SMA200
+15.0%
52-wk position
77.8% -8.1% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$50.18B$2.66B$1.76B$2.77B
2025-12-31$49.75B$581.0M$547.0M$987.0M
2025-09-30$50.71B$1.76B$1.19B$2.14B
2025-06-30$49.78B$2.63B$1.74B$3.01B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots